AEON Biopharma, Inc. (AEON) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.64M | -4.71M | -2.6M | -2.09M | -7.91M | -621K | -2.96M | -8.12M | -8.6M | -11.02M | -8.45M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 66.67% | -658.78% | 12.15% | 74.24% | 8.03% | 94.36% | - | - | - | -30.34% | - |
| Net Income | -11.79M | -37.14M | -4.54M | -6.64M | 9.1M | 2.08M | -6.17M | 164.11M | -118.02M | -26.24M | -34.56M |
| Depreciation & Amortization | 19K | 20K | 19K | 20K | 19K | 23K | 25K | 24K | 25K | 24K | 32K |
| Stock-Based Compensation | 0 | 0 | 0 | 1.58M | 1.73M | 1.34M | 1.59M | 1.69M | 1.62M | 1.7M | 1.67M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.82M | 33.51M | 1.11M | 2.41M | -12.94M | -7.36M | 2.17M | -171.84M | 107.68M | 14.32M | 19.67M |
| Working Capital Changes | 1.32M | -1.1M | 814K | 537K | -5.81M | 3.29M | -577K | -2.11M | 96K | -823K | 4.74M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 539K | -1.58M | 0 | 1.47M | -3.47M | 1.28M | 1.6M | -3.49M | 3.14M | 0 | 5.18M |
| Cash from Investing | 0 | 0 | 0 | 0 | -4K | 0 | 0 | 0 | 0 | 0 | -9K |
| Capital Expenditures | 0 | 0 | 0 | 0 | -4K | 0 | 0 | 0 | 0 | 0 | -9K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 5.87M | 1.79M | 84K | 84K | 18.35M | 97K | 50K | 10M | 5M | 0 | -3.99M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10M | 5M | 0 | -3.99M |
| Equity Issued (Net) | 1.67M | 1.79M | 84K | 84K | 18.35M | 97K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 4.21M | 0 | 0 | 0 | 0 | 0 | 50K | 0 | 0 | 0 | 0 |
| Net Change in Cash | 3.24M | -2.92M | -2.51M | -2.01M | 10.43M | -524K | -2.9M | 1.88M | -3.6M | -11.02M | -12.46M |
| Free Cash Flow | -2.64M | -4.71M | -2.6M | -2.09M | -7.91M | -621K | -2.96M | -8.12M | -8.6M | -11.02M | -8.46M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 66.69% | -658.78% | 12.15% | 74.24% | 7.99% | 94.36% | - | - | - | -30.2% | - |
| FCF per Share | -0.22 | -0.39 | -0.22 | -0.19 | -1.99 | -1.12 | -5.38 | -15.03 | -16.61 | -21.35 | -4.39 |
| FCF Conversion (FCF/Net Income) | 0.22x | 0.13x | 0.57x | 0.31x | -0.87x | -0.30x | 0.48x | -0.05x | 0.07x | 0.42x | 0.24x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |